Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2013
10/22/2013CA2430888C Nanosensors
10/22/2013CA2419474C Bioreactor and bioprocessing technique
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155525A1 Ultra rapid blood culturing and susceptibility testing system
10/17/2013WO2013155471A1 Method and apparatus for quantifying oxygen consumption of mitochondria
10/17/2013WO2013155460A1 Tuberculosis biomarkers and uses thereof
10/17/2013WO2013155374A2 Cholesterol efflux assay probe formulations, methods of making and using
10/17/2013WO2013155361A1 Methods for measuring polymerase activity useful for sensitive, quantitative measurements of any polymerase extension activity and for determining the presence of viable cells
10/17/2013WO2013155330A1 Compositions and methods for characterizing and treating muscular dystrophy
10/17/2013WO2013155290A1 Advanced reverse-phase magnetic immunoassay
10/17/2013WO2013155213A1 System and cartridge for efficient nucleic acid testing
10/17/2013WO2013155189A1 Detection of drug resistant mycobacterium tuberculosis
10/17/2013WO2013155119A1 Detection and quantitation of sample contamination in immune repertoire analysis
10/17/2013WO2013155085A1 Methods and biomarkers for osteoporosis
10/17/2013WO2013155077A1 Response markers for src inhibitor therapies
10/17/2013WO2013155056A1 Compositions and methods for quantifying a nucleic acid sequence in a sample
10/17/2013WO2013155010A1 Non-invasive biomarkers for eosinophilic esophagitis
10/17/2013WO2013154999A2 Method of preparation of nanopore and uses thereof
10/17/2013WO2013154998A1 Serum biomarkers and pulmonary nodule size for the early detection of lung cancer
10/17/2013WO2013154826A2 Methods for diagnosing impending diarrhea
10/17/2013WO2013154767A1 Compositions and methods for diagnosing and treating neoplasia
10/17/2013WO2013154750A1 Systems and methods for biological ion channel interfaces
10/17/2013WO2013154735A1 Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells
10/17/2013WO2013154590A1 Bioluminescent packaging
10/17/2013WO2013154429A1 Multiplex reporter assays for monitoring multiple variables
10/17/2013WO2013154422A1 Biomarkers for triple negative breast cancer
10/17/2013WO2013154304A2 Method for preparing a nucleic acid with high precision used in detecting a nucleic acid with a nucleic acid polymerase
10/17/2013WO2013154138A1 Method for detecting target nucleic acid using molecular beacon-type probe
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013154119A1 Method for quantifying subfraction of cholesterol (-c) in high-density lipoprotein (hdl)
10/17/2013WO2013153911A1 Nucleic acid quantification method, detection probe, detection probe set, and nucleic acid detection method
10/17/2013WO2013153524A1 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
10/17/2013WO2013153359A1 Mutant lysenin pores
10/17/2013WO2013153237A1 Qtl responsible for tomato fruit firmness
10/17/2013WO2013153139A1 Methods for the treatment and diagnosis of acute leukemia
10/17/2013WO2013153130A1 Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the dna base excision repair pathway
10/17/2013WO2013153083A1 Method for diagnosing a skeletal ciliopathy
10/17/2013WO2013152456A1 Maize authentication detection and molecular breeding snp chip - maizesnp3072 and detection method thereof
10/17/2013WO2013126793A3 Detection of shiga toxin genes in bacteria
10/17/2013WO2013126774A3 Microfluidic devices for capture of target species
10/17/2013WO2013110916A3 Method for amplifying nucleic acid in an absorbent body
10/17/2013WO2013081571A3 Isolated lyssavirus nucleic acid and protein sequences
10/17/2013WO2013080055A3 Molecular display method
10/17/2013WO2013052907A3 Methods and processes for non-invasive assessment of genetic variations
10/17/2013WO2012094683A3 System for and method of determining cancer prognosis and predicting response to therapy
10/17/2013WO2012094651A3 Scn5a splice variants for use in methods relating to sudden cardiac death
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130274574 Electrochemical Analyte Sensor
10/17/2013US20130274458 Genetic fingerprinting and identification method
10/17/2013US20130274315 Pro-angiogenic genes in ovarian tumor endothelial cell isolates
10/17/2013US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides
10/17/2013US20130274276 Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitors
10/17/2013US20130274220 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
10/17/2013US20130274195 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/17/2013US20130274184 Er stress relievers in beta cell protection
10/17/2013US20130274148 Portable genetic detection and analysis system and method
10/17/2013US20130274147 Integrated sample preparation systems and stabilized enzyme mixtures
10/17/2013US20130274140 MicroRNA Fingerprints During Human Megakaryocytopoiesis
10/17/2013US20130274138 Gene signatures for prediction of therapy-related myelodysplasia and methods for identification of patients at risk for development of the same
10/17/2013US20130274135 Compositions of toehold primer duplexes and methods of use
10/17/2013US20130274133 Genetic variations in the interleukin-6 receptor gene as predictors of the response of patients to treatment with interleukin-6 receptor inhibitors
10/17/2013US20130274132 Genetic Modifiers of Cystic Fibrosis
10/17/2013US20130274128 Gene expression in n-cadherin overexpressing prostate cancers and their controls
10/17/2013US20130274127 Gene expression markers for prediction of response to phosphoinositide 3-kinase inhibitors
10/17/2013US20130274126 Sensor chip and measurement method using the same
10/17/2013US20130274122 Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis pmpa gene
10/17/2013US20130274121 Diagnostic Method
10/17/2013US20130274120 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
10/17/2013US20130274117 High-Throughput Single Cell Barcoding
10/17/2013US20130274116 Methods for non-invasive prenatal ploidy calling
10/17/2013US20130274115 Method for pairwise sequencing of target polynucleotides
10/17/2013US20130273652 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273644 Nucleic acid amplification reaction station for disposable test devices
10/17/2013US20130273598 Articles and method for detecting a target microorganism
10/17/2013US20130273597 Procurement extraction bag
10/17/2013US20130273596 Neural crest enhancers and methods for use
10/17/2013US20130273594 Sterilization indicators including a porous carrier and methods
10/17/2013US20130273593 Sterilization indicators including a neutralizer and methods
10/17/2013US20130273592 Method for isolating a sample well of a test card for analysis, and resulting test card
10/17/2013US20130273587 Screen to identify agents that can modulate heme transporter
10/17/2013US20130273584 Serum preparation
10/17/2013US20130273583 Testing apparatus for detection of gastrointestinal disorders
10/17/2013US20130273567 Screening Method for Candidate Agonist Compounds for Adiponectin Receptor I
10/17/2013US20130273562 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target
10/17/2013US20130273553 Stabilization of cyclic peptide structures
10/17/2013US20130273549 Detection of extracellular jcv micrornas
10/17/2013US20130273547 Method to determine and correct baseline and to characterize pcr amplification kinetics
10/17/2013US20130273546 Low temperature enzyme and method thereof
10/17/2013US20130273545 Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease
10/17/2013US20130273543 Genetic variants useful for risk assessment of thyroid cancer
10/17/2013US20130273542 Detection of gleevec resistance
10/17/2013US20130273541 Breast Cancer Susceptibility Gene GT198 and Uses Thereof
10/17/2013US20130273540 Method for chromogenic detection of two or more target molecules in a single sample
10/17/2013US20130273539 Method for identifying olfactory receptor included in one olfactory cell
10/17/2013US20130273538 Method for identifying olfactory receptor included in one olfactory cell
10/17/2013US20130273537 Transcriptome In Vivo Analysis
10/17/2013US20130273535 Ndm-1 polymerase chain reaction (pcr) assay
10/17/2013US20130273534 Socs-3 promoter methylation in cancer
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 3003